Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Chaisson

Showing results (151-160 of 226) with videos related to

Pageof 23
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 15, 2005
Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence stateJ E Golub, S Bur, W A Cronin, et al.
The Journal of Infectious Diseases|November 17, 1998
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adultsM S Sulkowski, R E Chaisson, C L Karp, et al.
Deutsche Medizinische Wochenschrift (1946)|June 7, 1991
[HIV infection and tuberculosis]P M Small, G F Schecter, P C Goodman, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South AfricaJ B Nachega, D M Stein, D A Lehman, et al.
Archives of Internal Medicine|October 1, 1988
Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trialR E Chaisson, M D Leuther, J P Allain, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Immune serum markers and CD4 cell counts in HIV-infected intravenous drug usersR E Chaisson, E Taylor, J B Margolick, et al.
IJTLD Open|September 20, 2024
Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIVR Borse, B Randive, S Mattoo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 29, 2025
Reply to Authors: addressing concerns to ensure effective TB preventive therapyR Borse, B Randive, S Mattoo, et al.
AIDS Care|December 9, 2003
Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South AfricaS Charalambous, A D Grant, J H Day, et al.
The American Journal of Medicine|May 31, 2001
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug usersR E Chaisson, G L Barnes, J Hackman, et al.
Pageof 23

Showing results (151-160 of 226) with videos related to

Sort By:
Pageof 23
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 15, 2005
Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence stateJ E Golub, S Bur, W A Cronin, et al.
The Journal of Infectious Diseases|November 17, 1998
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adultsM S Sulkowski, R E Chaisson, C L Karp, et al.
Deutsche Medizinische Wochenschrift (1946)|June 7, 1991
[HIV infection and tuberculosis]P M Small, G F Schecter, P C Goodman, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South AfricaJ B Nachega, D M Stein, D A Lehman, et al.
Archives of Internal Medicine|October 1, 1988
Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trialR E Chaisson, M D Leuther, J P Allain, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Immune serum markers and CD4 cell counts in HIV-infected intravenous drug usersR E Chaisson, E Taylor, J B Margolick, et al.
IJTLD Open|September 20, 2024
Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIVR Borse, B Randive, S Mattoo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 29, 2025
Reply to Authors: addressing concerns to ensure effective TB preventive therapyR Borse, B Randive, S Mattoo, et al.
AIDS Care|December 9, 2003
Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South AfricaS Charalambous, A D Grant, J H Day, et al.
The American Journal of Medicine|May 31, 2001
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug usersR E Chaisson, G L Barnes, J Hackman, et al.
Pageof 23